Irish Mirror on MSN
Viral ‘filler in a bottle’ serum hailed for its effect on under-eye hollows goes on sale
The Ordinary's viral Volufiline serum is making waves on TikTok for plumping under-eye hollows and restoring facial volume - ...
The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.
The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of ...
The Ordinary’s new ‘filler in a bottle’ serum made me look ‘more youthful’ in my 40s - Can you restore lost volume without a ...
The reality TV stars all represent "the Utah" look, a beauty standard that strives for "perfect" conformity to conventional ...
13h
Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss
FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...
News-Medical.Net on MSN
Searches for “Ozempic face” surge as people look for filler-based solutions
Public interest in “Ozempic face” rose sharply from 2022 to 2025, mirrored by increased searches for nonsurgical facial ...
"I haven’t had Botox in over eight months because of this serum," one reviewer wrote of the Iope Bio-PDRN Caffeine Face Shot.
Analysts say the two new indications should help Eylea HD as Regeneron battles for market share with Roche’s Vabysmo.
The FDA also approved an every 4 week dosing regimen across all approved indications for patients who may not maintain a response on extended dosing intervals following successful initial treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback